The Food and Drug Administration has accepted and granted priority review to a new drug application for sunvozertinib.

Subcutaneous Sarclisa, administered via OBDS, showed non-inferior efficacy to IV Sarclisa in relapsed/refractory multiple ...

Obtaining a second opinion during your cancer treatment can be a daunting but also life-changing step; however, surprisingly ...

Dr. Balazs Halmos discusses the significance of the FDA approval of the subcutaneous injection formulation of Opdivo for ...

The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.

Adding hyperthermic intraperitoneal chemotherapy to surgery did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer.

At my routine oncology checkup, I regretted not bringing my husband when an unexpected medication changes left me feeling ...

After experiencing unexplained symptoms, I was diagnosed with multiple myeloma and underwent a stem cell transplant.

When I recognize my frustration and dissapointment with the test results for my chronic lymphocytic leukemia, I find comfort ...

P1101 had durable hematologic responses and manageable safety among patients with essential thrombocythemia, meeting the ...

The FDA has granted fast track designation for abenacianine to help surgeons better visualize lung tumors during minimally ...

CURE spoke with an expert about the potential positive effects of radiation therapy for patients with hepatocellular carcinoma.